Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-261
Authors: Weyerhäuser, Patrick
Kantelhardt, Sven Rainer
Kim, Ella
Title: Re-purposing chloroquine for glioblastoma : potential merits and confounding variables
Online publication date: 19-Dec-2018
Language: english
Abstract: Chloroquine, one of the oldest antimalarials, has been implicated as a therapeutic sensitizer in different types of cancers. Reflecting a growing attention to the anti-neoplastic actions of this drug, over thirty trials have been initiated within the past five years to test the potential of chloroquine as an adjuvant treatment for different types of therapy-refractory cancers. Glioblastoma is one of the most aggressive human cancers shown to have a better response to standard therapy when combined with chloroquine. While there is considerable evidence for the efficacy and safety of chloroquine as an adjuvant treatment for cancer, the mechanisms underlying the tumor suppressive actions of this drug remain elusive. Up until recently, inhibitory effects of chloroquine on the late stage of autophagy was thought to be the major mechanism underlying cancer cells death from chloroquine. However, recent research provided compelling evidence that autophagy-inhibiting activities of chloroquine are dispensable for its ability to suppress tumor cells growth. These unexpected findings urge to explore the role of autophagy-independent activities of chloroquine and molecular mechanisms underlying the anti-cancer effects of this interesting drug. This review discusses the versatile actions of chloroquine in cancer cells with particular focus on glioma cells.
DDC: 610 Medizin
610 Medical sciences
Institution: Johannes Gutenberg-Universität Mainz
Department: FB 04 Medizin
Place: Mainz
DOI: http://doi.org/10.25358/openscience-261
URN: urn:nbn:de:hebis:77-publ-587178
Version: Published version
Publication type: Zeitschriftenaufsatz
License: CC BY
Information on rights of use: https://creativecommons.org/licenses/by/4.0/
Journal: Frontiers in oncology
8
Pages or article number: Art. 335
Publisher: Frontiers Media
Publisher place: Lausanne
Issue date: 2018
ISSN: 2234-943X
Publisher URL: http://dx.doi.org/10.3389/fonc.2018.00335
Publisher DOI: 10.3389/fonc.2018.00335
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
Thumbnail
58717.pdf664.26 kBAdobe PDFView/Open